Company Search:
Advanced Search
Sponsored Links
Atrys Health SA Company Snapshot
Atrys Health SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Atrys Health SA with three other pharmaceutical manufacturers in Europe: Transgene of France (2018 sales of 7.08 million Euro [US$7.85 million] of which 81% was Research & Development Tax Credit), Biotec Pharmacon ASA of Norway (66.77 million Norwegian Kroner [US$7.44 million] of which 51% was Enzymes), and Biomed Lublin Wytwornia Surowic I Szczepionek SA which is based in Poland (32.29 million Polish New Zlotys [US$8.45 million] of which 100% was Traditional Segment).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Atrys Health SA
  Stock Performance Chart for Atrys Health SA
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 4.98
(Figures in Euro)
1 Week -2.4%   13 Weeks -0.4%  
4 Weeks 10.7%   52 Weeks 55.1%  
Atrys Health SA Key Data:
  Ticker: ATRY Country: Spain
  Exchanges: MAD Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 7,294,143
(Year Ending Jan 2019).
Employees: 99
  Currency: Euro Market Cap: 107,797,680
  Fiscal Yr Ends: December Shares Outstanding: 21,646,120
  Share Type: Accion Closely Held Shares: 9,985,093
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.